Splenectomy in hairy cell leukemia: a retrospective multicenter analysis

Area of Science:

• Hematology
• Oncology

Background:

• Hairy cell leukemia (HCL) is a rare lymphoid malignancy.
• Splenectomy is a treatment option for HCL, but its efficacy requires further investigation.

Purpose of the Study:

• To evaluate the impact of splenectomy on survival in patients with hairy cell leukemia.
• To identify prognostic factors associated with splenectomy outcomes in HCL.

Main Methods:

• Retrospective multicenter analysis of 391 hairy cell leukemia patients.
• Data pooled from 22 centers for comprehensive analysis.
• Comparison of survival rates between splenectomy and non-splenectomy groups.

Main Results:

• Splenectomy group showed significantly longer survival (P < 0.0001).
• Post-splenectomy improvements in platelet counts were common; neutrophil increases were less frequent.
• Patients achieving higher post-operative Hb, neutrophil, and platelet counts had better survival (P < 0.01).

Conclusions:

• Splenectomy is beneficial for HCL patients with splenomegaly and pancytopenia.
• For HCL patients without significant splenomegaly, alternative therapies should be considered.
• Achieving hematologic response post-splenectomy correlates with improved survival in HCL.